Related Experiment Video

Updated: Apr 5, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MicroRNA-145 inhibits human papillary cancer TPC1 cell proliferation by targeting DUSP6

Yifan Gu1, Dengfeng Li2, Qifeng Luo2

  • 1Department of General Surgery, Shanghai Tongren Hospital Shanghai 200335, China ; Tongji University School of Medicine Shanghai 200092, China.

International Journal of Clinical and Experimental Medicine
|August 27, 2015
PubMed

Insights

MicroRNA-145 (miR-145) is decreased in papillary thyroid cancer. Overexpressing miR-145 suppresses cancer cell growth by targeting DUSP6, offering insights into thyroid cancer progression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes.
  • Dysregulation of miRNAs is implicated in various human cancers, including thyroid cancer.

Purpose of the Study:

  • To investigate the expression levels of microRNA-145 (miR-145) in human papillary thyroid cancer.
  • To elucidate the functional role of miR-145 in papillary thyroid cancer cell proliferation and identify its target genes.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for miR-145 expression analysis.
  • MTT and colony-formation assays to assess cell proliferation upon miR-145 overexpression.
  • Western blot and luciferase reporter assays to validate miR-145 targets and their protein expression.

Main Results:

  • miR-145 expression was significantly reduced in papillary thyroid cancer tissues compared to adjacent normal tissues.
  • Overexpression of miR-145 inhibited the proliferation of TPC1 thyroid cancer cells.
  • miR-145 was confirmed to directly target DUSP6, and its overexpression led to decreased DUSP6 protein levels. Knockdown of DUSP6 also inhibited cell proliferation.

Conclusions:

  • miR-145 acts as a tumor suppressor in papillary thyroid cancer by targeting DUSP6.
  • The miR-145/DUSP6 axis represents a potential therapeutic target for papillary thyroid cancer.
  • Understanding miR-145's role provides insights into the molecular mechanisms driving papillary thyroid cancer initiation and progression.
Keywords:
DUSP6MiR-145papillary thyroid cancerproliferation

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K